Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Parikh

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Nature Communications|May 7, 2024
Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in childrenJustin Goodwin, Richard Kajubi, Kaicheng Wang, et al.
Emerging Infectious Diseases|April 26, 2021
SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USAHanna Y Ehrlich, Adora Harizaj, Lauren Campbell, et al.
Plos One|August 19, 2014
Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquineIssaka Zongo, Fabrice A Somé, Serge A M Somda, et al.
Emerging Infectious Diseases|July 21, 2021
Four Human Cases of Eastern Equine Encephalitis in Connecticut, USA, during a Larger Regional Outbreak, 2019Stacy C Brown, Justine Cormier, Jessica Tuan, et al.
Journal of Clinical Pharmacology|January 24, 2025
Extended Treatment Duration of Artemether-Lumefantrine in Ugandan Children with HIV on Efavirenz-Based Antiretroviral Therapy: A Randomized Controlled Pharmacokinetic and Pharmacodynamic TrialMeghan E Whalen, Richard Kajubi, Justin Goodwin, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum MalariaMyaing M Nyunt, Vy K Nguyen, Richard Kajubi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2016
Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan ChildrenSunil Parikh, Richard Kajubi, Liusheng Huang, et al.
Malaria Journal|June 8, 2025
Household practices and infrastructure associated with high Plasmodium falciparum infection rates among children under five years old in Northern UgandaRichard Echodu, Sandra Ajolorwot, Frida Aryemo, et al.
Open Forum Infectious Diseases|December 27, 2016
Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan ChildrenRichard Kajubi, Liusheng Huang, Moses Were, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2022
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled TrialMeghan E Whalen, Richard Kajubi, Justin Goodwin, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Nature Communications|May 7, 2024
Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in childrenJustin Goodwin, Richard Kajubi, Kaicheng Wang, et al.
Emerging Infectious Diseases|April 26, 2021
SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USAHanna Y Ehrlich, Adora Harizaj, Lauren Campbell, et al.
Plos One|August 19, 2014
Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquineIssaka Zongo, Fabrice A Somé, Serge A M Somda, et al.
Emerging Infectious Diseases|July 21, 2021
Four Human Cases of Eastern Equine Encephalitis in Connecticut, USA, during a Larger Regional Outbreak, 2019Stacy C Brown, Justine Cormier, Jessica Tuan, et al.
Journal of Clinical Pharmacology|January 24, 2025
Extended Treatment Duration of Artemether-Lumefantrine in Ugandan Children with HIV on Efavirenz-Based Antiretroviral Therapy: A Randomized Controlled Pharmacokinetic and Pharmacodynamic TrialMeghan E Whalen, Richard Kajubi, Justin Goodwin, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum MalariaMyaing M Nyunt, Vy K Nguyen, Richard Kajubi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2016
Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan ChildrenSunil Parikh, Richard Kajubi, Liusheng Huang, et al.
Malaria Journal|June 8, 2025
Household practices and infrastructure associated with high Plasmodium falciparum infection rates among children under five years old in Northern UgandaRichard Echodu, Sandra Ajolorwot, Frida Aryemo, et al.
Open Forum Infectious Diseases|December 27, 2016
Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan ChildrenRichard Kajubi, Liusheng Huang, Moses Were, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2022
The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled TrialMeghan E Whalen, Richard Kajubi, Justin Goodwin, et al.
Pageof 9